Godavari Biorefineries Limited

NSE: GODAVARIBFast Moving Consumer Goods

Godavari Biorefineries Limited Share Price & Analysis

₹201.94+0.14%Updated 28 Oct 2026, 03:30 pm IST
LTP
₹201.94+0.14%
Open
₹202.00
High
₹203.24
Low
₹198.93
Close
₹201.94
52W High
₹354.00
52W Low
₹193.60
Volume
49K
Lot Size
1
Sector
Fast Moving Consumer Goods
Market Cap
₹1K Cr
Face Value
₹10
Small Cap

Price Chart

Candle
Range

Fundamentals

P/E
40.10
Sector P/E
37.50
P/B
—
EPS
₹4.41
ROE
4.08%
ROCE
6.43%
D/E Ratio
0.67
Div Yield
0.00%
Book Value
₹154.00

Strengths

  • Near 52-week low — potential value zone (₹194)

Concerns

    Peer Comparison

    CompanyCMPMkt CapP/EP/BROE %ROCE %D/E
    HINDUNILVR
    Hindustan Unilever Limited
    ₹1,816
    ₹4.3L Cr38.78.773128.40.04
    ITC
    ITC Limited
    ₹260
    ₹3.2L Cr16.44.4829.338.90.01
    NESTLEIND
    Nestle India Limited
    ₹1,168
    ₹2.3L Cr5738.9374.285.30.08
    VBL
    Varun Beverages Limited
    ₹405
    ₹1.3L Cr39.56.9916.219.70.13
    BRITANNIA
    Britannia Industries Limited
    ₹4,567
    ₹1.1L Cr4221.5453.5560.59
    MARICO
    Marico Limited
    ₹770
    ₹100K Cr52.823.7542.8470.14
    TATACONSUM
    TATA CONSUMER PRODUCTS LIMITED
    ₹1,000
    ₹95K Cr57.84.557.359.240.13

    Showing 7 peers in the same sector · Sorted by market cap

    Shareholding Pattern

    GODAVARIB · as of Jun 2026

    Promoters63.31%
    FII0.22%0.76pp
    DII10.02%0.37pp
    Public26.44%1.13pp
    CategoryMar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
    Promoters63.31%63.31%63.31%63.31%63.31%63.31%
    FII0.96%0.63%0.60%0.86%0.98%0.22%
    DII14.17%13.98%11.98%11.16%10.39%10.02%
    Public21.56%22.09%24.11%24.67%25.31%26.44%

    Corporate Events

    To consider and approve the financial results for the quarter and year ended on March 31, 2026

    Results21 May 2026

    Latest News

    All news

    Oil India finds gas in Krishna Godavari basin

    *Oil India discovers natural gas in Krishna Godavari basin.* This is a significant find in a key sedimentary basin, boosting exploration prospects. The discovery could lead to **increased reserves** and **higher production** potential, positively impacting future revenue. Further appraisal will determine commercial viability. 📊 *STOCKS:* $OIL | 🏢 *SECTOR:* Energy | #HIGHIMPACT #Exploration

    scanx.trade5d ago
    High Impact

    Oil India discovers natural gas in KG basin

    *Oil India discovers natural gas in KG basin.* OIL announced a discovery of natural gas in the shallow offshore KG-DSF/GSKW/2018 block in the Krishna Godavari basin. The find could boost domestic gas reserves and future production capacity. Further appraisal will determine commercial viability. 📊 *STOCKS:* $OIL | 🏢 *SECTOR:* Energy | #MEDIUMIMPACT #Exploration

    NSE Filing5d ago
    Medium Impact

    Godawari disposes stake in associate firm Jammu Pigments

    *Godawari disposes stake in associate firm Jammu Pigments* — Godawari Power has announced the disposal of its entire stake in Jammu Pigments Limited, an associate company. The transaction marks a strategic divestment, though financial details like **deal value** or **stake percentage** were not disclosed. This move could unlock value for shareholders and streamline operations. 📊 *STOCKS:* $GODAVARISUG | 🏢 *SECTOR:* CapitalMarkets | #MEDIUMIMPACT #StakeSale

    NSE Filing14 Oct
    Medium Impact

    Godavari Biorefineries secures European patent for pharmaceutical composition

    *Godavari Biorefineries secures European patent for pharmaceutical composition.* The European Patent Office has granted a patent for its 'Pharmaceutical Composition and a Process to Prepare the Same'. This strengthens the company's intellectual property portfolio and may enhance product differentiation in international markets. The development reflects ongoing R&D efforts in specialty pharma formulations. 📊 *STOCKS:* $GODAVARI | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #Patent

    NSE Filing11 Aug
    Medium Impact

    Godavari Biorefineries wins cancer treatment patent in Japan

    *Godavari Biorefineries wins cancer treatment patent in Japan*. The Japanese Patent Office granted a patent for '5-HYDROXY-1,4-NAPHTHALENEDIONE FOR USE IN THE TREATMENT OF CANCER'. This strengthens GBRL’s global IP portfolio and validates its R&D focus in oncology. Clinical and commercial success could drive future revenue streams. 📊 *STOCKS:* GBRL | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #Patent

    NSE Filing16 Jun
    Medium Impact

    Oil India discovers new gas reserve in KG Basin

    *Oil India discovers new gas reserve in KG Basin* reports a fresh natural gas find in the Krishna-Godavari Basin. The discovery could boost domestic production and future revenue. Details on reserve size and commercial viability are awaited. 📊 *STOCKS:* $OIL | 🏢 *SECTOR:* Energy | #MEDIUMIMPACT #Exploration

    Offshore Technology2d ago
    Medium Impact

    Oil India finds gas in KG offshore block

    *Oil India finds gas in KG offshore block.* The discovery in the Krishna-Godavari basin marks a significant exploration success. Initial estimates suggest potential reserves of **over 100 mmcfd** of natural gas. This could boost production and reduce import dependence. 📊 *STOCKS:* $OIL | 🏢 *SECTOR:* Energy | #MEDIUMIMPACT #Exploration

    Sarkaritel.com5d ago
    Medium Impact

    Godawari Power arm secures clearance for 20 GWh battery project

    *Godawari Power arm secures clearance for 20 GWh battery project.* The environmental nod for the **20 GWh** battery storage facility in Maharashtra marks a key milestone. This positions the company to play a major role in India’s energy storage sector. The project supports grid stability and renewable integration. 📊 *STOCKS:* $GODAVARI | 🏢 *SECTOR:* Energy | #MEDIUMIMPACT #BatteryStorage

    India CSR7 Oct
    Medium Impact

    Godavari Biorefineries closes trading window ahead of results

    *Godavari Biorefineries closes trading window ahead of results* as per SEBI regulations. The closure is a routine compliance measure ahead of upcoming financial disclosures. No trading by insiders is permitted during this period. 📊 *STOCKS:* $GODAVARI | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #InsiderTrading

    NSE Filing28 Sept
    Low Impact

    Godavari Biorefineries files patent for viral infection treatment

    *Godavari Biorefineries files patent for treating viral infections.* The company submitted a filing regarding the use of certain compounds for antiviral therapy. While early-stage, the development signals R&D progress. No financial figures or commercialization timeline were disclosed. 📊 *STOCKS:* $GODAVARI | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Pharma

    NSE Filing16 Sept
    Low Impact

    Financials

    Quarterly Results

    MetricDec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    Revenue
    ₹460 Cr
    6.7%
    ₹431 Cr
    19.1%
    ₹533 Cr
    8.1%
    ₹580 Cr
    29.8%
    ₹447 Cr
    39.3%
    ₹321 Cr
    38.6%
    ₹523 Cr
    15.0%
    ₹615.19 Cr
    Op. Profit
    ₹43 Cr
    637.5%
    ₹-8 Cr
    233.3%
    ₹6 Cr
    94.6%
    ₹112 Cr
    211.1%
    ₹36 Cr
    209.1%
    ₹-33 Cr
    175.0%
    ₹-12 Cr
    110.5%
    ₹113.83 Cr
    OPM
    9.0%
    550.0%
    -2.0%
    300.0%
    1.0%
    94.7%
    19.0%
    137.5%
    8.0%
    180.0%
    -10.0%
    400.0%
    -2.0%
    110.8%
    18.5%
    Net Profit
    ₹8 Cr
    119.0%
    ₹-42 Cr
    162.5%
    ₹-16 Cr
    122.2%
    ₹72 Cr
    1100.0%
    ₹6 Cr
    108.0%
    ₹-75 Cr
    188.5%
    ₹-26 Cr
    139.9%
    ₹65.17 Cr
    EPS (₹)
    1.61
    119.8%
    -8.13
    159.7%
    -3.13
    122.3%
    14.06
    1144.2%
    1.13
    106.3%
    -17.88
    187.0%
    -6.23
    140.1%
    15.54

    Values in ₹ Cr · Source: Screener.in

    Annual Profit & Loss

    MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
    Revenue
    ₹2.0K Cr
    6.3%
    ₹1.9K Cr
    10.8%
    ₹1.7K Cr
    16.3%
    ₹2.0K Cr
    18.4%
    ₹1.7K Cr
    10.7%
    ₹1.5K Cr
    5.4%
    ₹1.5K Cr
    Expenses
    ₹1.9K Cr
    5.4%
    ₹1.8K Cr
    13.7%
    ₹1.6K Cr
    16.8%
    ₹1.9K Cr
    19.1%
    ₹1.6K Cr
    13.5%
    ₹1.4K Cr
    1.8%
    ₹1.4K Cr
    Op. Profit
    ₹127 Cr
    22.1%
    ₹104 Cr
    22.4%
    ₹134 Cr
    8.8%
    ₹147 Cr
    9.7%
    ₹134 Cr
    15.2%
    ₹158 Cr
    53.4%
    ₹103 Cr
    OPM
    6.0%
    0.0%
    6.0%
    25.0%
    8.0%
    14.3%
    7.0%
    12.5%
    8.0%
    20.0%
    10.0%
    42.9%
    7.0%
    Other Income
    ₹-19 Cr
    218.8%
    ₹16 Cr
    14.3%
    ₹14 Cr
    100.0%
    ₹7 Cr
    16.7%
    ₹6 Cr
    25.0%
    ₹8 Cr
    42.9%
    ₹14 Cr
    Interest
    ₹49 Cr
    31.9%
    ₹72 Cr
    5.3%
    ₹76 Cr
    4.1%
    ₹73 Cr
    21.7%
    ₹60 Cr
    16.7%
    ₹72 Cr
    4.3%
    ₹69 Cr
    Depreciation
    ₹54 Cr
    8.0%
    ₹50 Cr
    16.7%
    ₹60 Cr
    20.0%
    ₹50 Cr
    4.2%
    ₹48 Cr
    2.1%
    ₹47 Cr
    4.4%
    ₹45 Cr
    PBT
    ₹5 Cr
    350.0%
    ₹-2 Cr
    116.7%
    ₹12 Cr
    62.5%
    ₹32 Cr
    0.0%
    ₹32 Cr
    30.4%
    ₹46 Cr
    1433.3%
    ₹3 Cr
    Tax %
    23.0%
    98.4%
    1421.0%
    142000.0%
    1.0%
    97.4%
    38.0%
    5.0%
    40.0%
    2.4%
    41.0%
    270.8%
    -24.0%
    Net Profit
    ₹4 Cr
    117.4%
    ₹-23 Cr
    291.7%
    ₹12 Cr
    40.0%
    ₹20 Cr
    5.3%
    ₹19 Cr
    29.6%
    ₹27 Cr
    575.0%
    ₹4 Cr
    EPS (₹)
    0.69
    115.1%
    -4.57
    256.0%
    2.93
    37.4%
    4.68
    2.9%
    4.55
    29.7%
    6.47
    567.0%
    0.97
    Div Payout
    0.0%
    0.0%
    0.0%
    0.0%
    0.0%
    0.0%
    0.0%

    Values in ₹ Cr · Source: Screener.in

    Balance Sheet

    ItemMar 2026Sep 2025Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
    Liabilities
    Equity Capital
    ₹51 Cr
    0.0%
    ₹51 Cr
    0.0%
    ₹51 Cr
    21.4%
    ₹42 Cr
    0.0%
    ₹42 Cr
    0.0%
    ₹42 Cr
    0.0%
    ₹42 Cr
    0.0%
    ₹42 Cr
    Reserves
    ₹737 Cr
    9.3%
    ₹674 Cr
    7.8%
    ₹731 Cr
    59.3%
    ₹459 Cr
    2.5%
    ₹448 Cr
    3.9%
    ₹431 Cr
    4.6%
    ₹412 Cr
    7.0%
    ₹385 Cr
    Borrowings
    ₹531 Cr
    7.7%
    ₹493 Cr
    0.6%
    ₹490 Cr
    25.2%
    ₹655 Cr
    11.0%
    ₹736 Cr
    15.7%
    ₹636 Cr
    11.8%
    ₹569 Cr
    3.4%
    ₹589 Cr
    Other Liabilities
    ₹733 Cr
    198.0%
    ₹246 Cr
    64.0%
    ₹683 Cr
    18.3%
    ₹836 Cr
    61.4%
    ₹518 Cr
    17.1%
    ₹625 Cr
    49.2%
    ₹419 Cr
    0.2%
    ₹418 Cr
    Total Liabilities
    ₹2.1K Cr
    40.3%
    ₹1.5K Cr
    25.2%
    ₹2.0K Cr
    1.9%
    ₹2.0K Cr
    14.2%
    ₹1.7K Cr
    0.6%
    ₹1.7K Cr
    20.2%
    ₹1.4K Cr
    0.6%
    ₹1.4K Cr
    Assets
    Fixed Assets
    ₹885 Cr
    2.9%
    ₹860 Cr
    0.2%
    ₹862 Cr
    1.4%
    ₹850 Cr
    1.8%
    ₹866 Cr
    29.8%
    ₹667 Cr
    5.8%
    ₹708 Cr
    3.7%
    ₹735 Cr
    CWIP
    ₹129 Cr
    59.3%
    ₹81 Cr
    118.9%
    ₹37 Cr
    27.6%
    ₹29 Cr
    70.6%
    ₹17 Cr
    66.0%
    ₹50 Cr
    455.6%
    ₹9 Cr
    47.1%
    ₹17 Cr
    Investments
    ₹0 Cr
    ₹0 Cr
    ₹0 Cr
    ₹0 Cr
    ₹0 Cr
    ₹0 Cr
    ₹0 Cr
    ₹0 Cr
    Other Assets
    ₹1.0K Cr
    98.9%
    ₹522 Cr
    50.5%
    ₹1.1K Cr
    5.2%
    ₹1.1K Cr
    29.4%
    ₹860 Cr
    15.4%
    ₹1.0K Cr
    40.1%
    ₹725 Cr
    6.1%
    ₹683 Cr
    Total Assets
    ₹2.1K Cr
    40.3%
    ₹1.5K Cr
    25.2%
    ₹2.0K Cr
    1.9%
    ₹2.0K Cr
    14.2%
    ₹1.7K Cr
    0.6%
    ₹1.7K Cr
    20.2%
    ₹1.4K Cr
    0.6%
    ₹1.4K Cr

    Values in ₹ Cr · Source: Screener.in

    Cash Flow Statement

    ItemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
    Operating CF
    ₹171 Cr
    2750.0%
    ₹6 Cr
    96.8%
    ₹185 Cr
    6.1%
    ₹197 Cr
    337.8%
    ₹45 Cr
    65.4%
    ₹130 Cr
    48.0%
    ₹250 Cr
    Investing CF
    ₹-163 Cr
    136.2%
    ₹-69 Cr
    56.8%
    ₹-44 Cr
    79.4%
    ₹-214 Cr
    345.8%
    ₹-48 Cr
    585.7%
    ₹-7 Cr
    69.6%
    ₹-23 Cr
    Financing CF
    ₹-6 Cr
    109.4%
    ₹64 Cr
    142.4%
    ₹-151 Cr
    639.3%
    ₹28 Cr
    366.7%
    ₹6 Cr
    105.0%
    ₹-121 Cr
    46.5%
    ₹-226 Cr
    Net Cash Flow
    ₹3 Cr
    200.0%
    ₹1 Cr
    110.0%
    ₹-10 Cr
    190.9%
    ₹11 Cr
    266.7%
    ₹3 Cr
    50.0%
    ₹2 Cr
    100.0%
    ₹1 Cr
    Free Cash Flow
    ₹6 Cr
    109.2%
    ₹-65 Cr
    150.0%
    ₹130 Cr
    750.0%
    ₹-20 Cr
    300.0%
    ₹-5 Cr
    104.2%
    ₹119 Cr
    46.6%
    ₹223 Cr

    Values in ₹ Cr · Source: Screener.in

    Key Ratios History

    MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
    Debtor Days
    21d
    22.2%
    27d
    34.1%
    41d
    10.8%
    37d
    0.0%
    37d
    7.5%
    40d
    29.0%
    31d
    Inventory Days
    198d
    1.5%
    195d
    22.0%
    250d
    82.5%
    137d
    31.5%
    200d
    37.0%
    146d
    12.3%
    130d
    Days Payable
    146d
    4.3%
    140d
    28.2%
    195d
    85.7%
    105d
    40.3%
    176d
    33.3%
    132d
    7.3%
    123d
    Cash Conv. Cycle
    74d
    9.8%
    82d
    13.7%
    95d
    39.7%
    68d
    11.5%
    61d
    10.9%
    55d
    41.0%
    39d
    Working Capital Days
    16d
    23.8%
    21d
    250.0%
    -14d
    800.0%
    2d
    33.3%
    3d
    200.0%
    1d
    101.5%
    -68d
    ROCE
    7.0%
    16.7%
    6.0%
    14.3%
    7.0%
    22.2%
    9.0%
    0.0%
    9.0%
    25.0%
    12.0%
    —

    Source: Screener.in · Lower days = better efficiency

    About Godavari Biorefineries Limited

    Incorporated in 1939, Godavari Biorefineries Ltd is a manufacturer of Bio-based Chemicals and Ethanol[1]

    Fast Moving Consumer GoodsDiversified FMCG

    Frequently Asked Questions

    What is Godavari Biorefineries Limited share price today?
    Godavari Biorefineries Limited (GODAVARIB) is currently trading at ₹201.94 on NSE, up 0.14% as of the last market session. Prices update daily after market close on MarketNetra.
    Is Godavari Biorefineries Limited available in F&O (Futures & Options)?
    Yes, Godavari Biorefineries Limited (GODAVARIB) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
    What is Godavari Biorefineries Limited 52-week high and low?
    Godavari Biorefineries Limited's 52-week high is ₹354 and the 52-week low is ₹193.6. The current price of ₹201.94 is 43.0% below the 52W high.
    What is Godavari Biorefineries Limited P/E ratio?
    Godavari Biorefineries Limited's current P/E ratio is 40.1. This indicates the market is paying ₹40.1 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
    How to trade Godavari Biorefineries Limited options?
    Godavari Biorefineries Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade GODAVARIB options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.